KLK3 and cancer: According to these considerations PCa screening using a PSA-based threshold as the sole indication for prostate biopsy lacks specificity, resulting in large numbers of unnecessary biopsies and, at the same time, in missing cancer diagnoses in men with PSA levels below the cut-off value [3].